Nature Reviews Disease Primers

Scope & Guideline

Bridging Research and Practice in Medicine

Introduction

Welcome to your portal for understanding Nature Reviews Disease Primers, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2056-676x
PublisherNATURE PORTFOLIO
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2015 to 2024
AbbreviationNAT REV DIS PRIMERS / Nat. Rev. Dis. Primers
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

Nature Reviews Disease Primers aims to provide comprehensive overviews and updates on various diseases, focusing on their pathophysiology, clinical features, and management strategies. The journal is dedicated to synthesizing current knowledge and offering insights into the latest developments in disease research and treatment.
  1. Comprehensive Disease Reviews:
    The journal publishes detailed reviews on a wide range of diseases, addressing their etiology, pathophysiology, clinical presentation, and management strategies.
  2. Emphasis on Rare and Common Disorders:
    Nature Reviews Disease Primers covers both prevalent conditions and rare diseases, ensuring a broad spectrum of health topics is addressed, which is crucial for both clinical and research communities.
  3. Interdisciplinary Approach:
    The journal encourages contributions that incorporate insights from various fields such as genetics, immunology, and epidemiology, reflecting a holistic view of disease understanding.
  4. Focus on Evidence-Based Medicine:
    Papers often emphasize evidence-based practices, highlighting recent clinical trials and studies that inform current treatment protocols.
  5. Public Health Implications:
    The journal also focuses on the public health aspects of diseases, including their epidemiology, prevention strategies, and health policy implications.
Recent publications in Nature Reviews Disease Primers indicate a shift towards certain emerging themes, reflecting current health challenges and research interests.
  1. Chronic Diseases and Multimorbidity:
    There is an increasing focus on chronic diseases and the concept of multimorbidity, highlighting the complexity of managing patients with multiple health issues.
  2. Mental Health Disorders:
    An emerging trend is the heightened attention to mental health conditions, reflecting the growing recognition of their impact on overall health and the need for integrated care approaches.
  3. Health Disparities and Social Determinants:
    Recent publications emphasize health disparities and the social determinants of health, indicating a broader interest in how socio-economic factors influence disease outcomes and healthcare access.
  4. Innovative Treatment Modalities:
    There is a growing trend towards discussing novel therapeutic approaches, including precision medicine and gene therapy, which reflect advancements in technology and treatment options.
  5. Patient-Centered Care and Shared Decision-Making:
    The journal is increasingly featuring themes around patient-centered care and shared decision-making, underscoring the importance of involving patients in their treatment choices.

Declining or Waning

While Nature Reviews Disease Primers continues to evolve, certain themes have shown a decrease in publication frequency. This may reflect shifting research priorities or advancements in understanding specific conditions.
  1. Traditional Infectious Diseases:
    There has been a noticeable decline in the frequency of reviews focusing on traditional infectious diseases, possibly due to the emergence of new pathogens and public health priorities shifting towards chronic diseases and complex health conditions.
  2. Basic Pathophysiological Mechanisms:
    There appears to be a waning interest in purely theoretical discussions on basic pathophysiological mechanisms, as the journal increasingly favors reviews that integrate clinical insights and therapeutic implications.
  3. Narrow Specialization:
    Papers focusing on highly specialized or niche diseases have become less common, suggesting a trend towards broader reviews that encompass related conditions and interdisciplinary approaches.

Similar Journals

TURKISH JOURNAL OF PEDIATRICS

Exploring the frontiers of child health and well-being.
Publisher: TURKISH J PEDIATRICSISSN: 0041-4301Frequency: 6 issues/year

The Turkish Journal of Pediatrics is a reputable peer-reviewed publication dedicated to advancing the field of pediatrics and child health. Published by the Turkish J Pediatrics, this journal boasts a rich history since its inception in 1963 and is integral to the dissemination of pediatric research in Turkey and beyond. With a Q3 ranking in the Pediatrics, Perinatology and Child Health category as per the 2023 Scopus metrics, it remains a significant contributor to academic discourse, despite presenting challenges in visibility with its current rank of #204/330. Researchers, professionals, and students in pediatric medicine will find valuable insights, original research articles, and comprehensive reviews that reflect contemporary issues and advancements in child health practices. Access to the journal is traditionally via subscription, emphasizing the importance of institutional backing in growing the next generation of pediatric research and practice.

ANNALS OF INTERNAL MEDICINE

Transforming Healthcare through Evidence-Based Knowledge
Publisher: AMER COLL PHYSICIANSISSN: 0003-4819Frequency: 12 issues/year

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

International Journal of Pediatrics

Advancing Pediatric Knowledge for a Healthier Future
Publisher: HINDAWI LTDISSN: 1687-9740Frequency: 1 issue/year

International Journal of Pediatrics is a reputable peer-reviewed publication dedicated to advancing the field of pediatrics, providing a pivotal platform for researchers, clinicians, and academics to share innovative findings and comprehensive reviews. Published by HINDAWI LTD in the United Kingdom, this journal has embraced the open access model since 2009, ensuring that high-quality pediatric research is freely available to a global audience. With a solid Q2 ranking in the leading field of "Pediatrics, Perinatology and Child Health" and a commendable Scopus rank of #100 out of 330, the journal is committed to disseminating impactful knowledge that enhances child health and well-being. Covering a broad scope of topics, from clinical studies to public health initiatives, it welcomes diverse research contributions to foster collaboration and engagement within the pediatric community. The journal’s ongoing publication since 2019 reinforces its relevance and dedication to improving the lives of children worldwide.

AUTOIMMUNITY REVIEWS

Unveiling breakthroughs in autoimmune disorders.
Publisher: ELSEVIERISSN: 1568-9972Frequency: 8 issues/year

AUTOIMMUNITY REVIEWS is an esteemed journal in the field of immunology and allergy, published by Elsevier and located in the Netherlands. With a remarkable impact reflected in its Q1 category rankings for both Immunology and Allergy, this journal stands at the forefront of advancing research and knowledge in autoimmune diseases. Its Scopus rankings are particularly notable, placing it at #14 in the Immunology and Allergy category and #17 in the broader scope of Immunology and Microbiology, underscoring its influential role in the scientific community with a commendable 94th percentiles in both domains. Since its inception in 2002, AUTOIMMUNITY REVIEWS has provided a multidisciplinary platform for researchers and practitioners to share landmark studies, case reports, and reviews that propel the understanding of autoimmune disorders. Although it does not currently operate under an open-access model, the journal ensures rigorous peer review and high-quality publications, making it an essential resource for anyone looking to stay informed about the latest developments in autoimmune research.

Byulleten Sibirskoy Meditsiny

Championing Open Access to Transform Healthcare Solutions
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Clinical Medicine Insights-Pediatrics

Empowering Pediatric Care with Evidence-Based Knowledge
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5565Frequency: 1 issue/year

Clinical Medicine Insights-Pediatrics, published by SAGE Publications Ltd, stands at the forefront of pediatric healthcare research, providing an essential platform for the dissemination of innovative findings and clinical advances. As an Open Access journal since 2010, it ensures that high-quality research is accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, healthcare professionals, and educators. Although the journal's H-index and Scopus Ranks are not specified, it remains committed to enhancing understanding and treatment of pediatric conditions by publishing rigorous studies, reviews, and case reports. With a focus on evidence-based practices and clinical insights, Clinical Medicine Insights-Pediatrics plays a pivotal role in addressing the unique health challenges faced by children today, making it an indispensable resource for anyone dedicated to advancing pediatric health.

JOURNAL OF INFECTIOUS DISEASES

Unraveling Complexities in Infectious Disease Research
Publisher: OXFORD UNIV PRESS INCISSN: 0022-1899Frequency: 24 issues/year

The JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.

NATURE REVIEWS IMMUNOLOGY

Exploring the Frontiers of Immune Research
Publisher: NATURE PORTFOLIOISSN: 1474-1733Frequency: 12 issues/year

NATURE REVIEWS IMMUNOLOGY, published by NATURE PORTFOLIO, is a premier journal dedicated to advancing the field of immunology through comprehensive and influential research reviews. With an impressive impact factor reflecting its status as a leading resource—ranked #1/236 in Immunology and Microbiology with a 99th percentile standing—this journal serves as a crucial repository of information for researchers, professionals, and students alike. The journal covers a wide array of topics within immunology, including the latest insights into immune responses and therapeutic applications, making it an essential resource for staying abreast of emerging trends and breakthroughs. Though not an open access journal, its rigorous peer-review process ensures that only the most relevant and high-quality articles are published. With converged years from 2001 to 2024 and a category quartile ranking of Q1 in multiple relevant fields, NATURE REVIEWS IMMUNOLOGY continues to shape the dialogue in immunological research and clinical practice on a global scale.

NATURE MEDICINE

Catalyzing Change in Healthcare through High-Impact Findings
Publisher: NATURE PORTFOLIOISSN: 1078-8956Frequency: 12 issues/year

NATURE MEDICINE, published by NATURE PORTFOLIO, is a premier journal in the fields of medicine and biochemistry, recognized for its rigorous peer-review process and high-impact research contributions. With an impressive Scopus ranking placing it in the top percentile—#3 out of 636 in General Medicine and #2 out of 221 in General Biochemistry, Genetics, and Molecular Biology—it embodies excellence and innovation in biomedical science. The journal has been a vital source of cutting-edge discoveries since its inception in 1995, and it encompasses a wide range of topics including clinical research, translational medicine, and advances in genetic technologies. The journal’s impact factor reflects its significance, making it an essential resource for researchers, professionals, and students aiming to stay at the forefront of medical science. Though the journal follows a subscription model, it remains crucial for disseminating pivotal research findings that shape the future of healthcare and therapeutic strategies worldwide.

Revista da Sociedade Brasileira de Medicina Tropical

Transforming challenges into solutions in tropical medicine.
Publisher: SOC BRASILEIRA MEDICINA TROPICALISSN: 0037-8682Frequency: 6 issues/year

Revista da Sociedade Brasileira de Medicina Tropical is a distinguished open-access journal published by the Sociedade Brasileira de Medicina Tropical, focusing on the critical fields of Infectious Diseases, Microbiology, and Parasitology. Since its inception in 1972, this journal has committed to disseminating impactful research that addresses pressing global health challenges, particularly in tropical and infectious diseases prevalent in Brazil and beyond. With a robust publication history, it has been recognized as a Q3 journal in esteemed categories, reflecting its valuable contributions to scientific literature and its ranking in various Scopus categories, including a notable position in Parasitology. Researchers, professionals, and students are encouraged to engage with its rich repository of research, which has been freely accessible since 1997, fostering a wide-reaching impact on public health strategy and scientific innovation.